115 related articles for article (PubMed ID: 16002456)
21. Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease.
Ishida C; Okino S; Kitamoto T; Yamada M
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):325-9. PubMed ID: 15716520
[TBL] [Abstract][Full Text] [Related]
22. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.
Ferrer I; Puig B; Blanco R; Martí E
Neuroscience; 2000; 97(4):715-26. PubMed ID: 10842016
[TBL] [Abstract][Full Text] [Related]
23. A novel subtype of Creutzfeldt-Jakob disease characterized by a small 6 kDa PrP fragment.
Krebs B; Bader B; Klehmet J; Grasbon-Frodl E; Oertel WH; Zerr I; Stricker S; Zschenderlein R; Kretzschmar HA
Acta Neuropathol; 2007 Aug; 114(2):195-9. PubMed ID: 17576581
[TBL] [Abstract][Full Text] [Related]
24. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
[TBL] [Abstract][Full Text] [Related]
25. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
[TBL] [Abstract][Full Text] [Related]
26. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.
Minaki H; Sasaki K; Honda H; Iwaki T
Neuropathology; 2009 Oct; 29(5):536-42. PubMed ID: 19389076
[TBL] [Abstract][Full Text] [Related]
27. Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18383623
[TBL] [Abstract][Full Text] [Related]
28. A quantitative and qualitative analysis of prion protein immunohistochemical staining in Creutzfeldt-Jakob disease using four anti prion protein antibodies.
MacDonald ST; Sutherland K; Ironside JW
Neurodegeneration; 1996 Mar; 5(1):87-94. PubMed ID: 8731387
[TBL] [Abstract][Full Text] [Related]
29. Neuropathology of variant Creutzfeldt-Jakob disease.
Ironside JW; Head MW; McCardle L; Knight R
Acta Neurobiol Exp (Wars); 2002; 62(3):175-82. PubMed ID: 12416395
[TBL] [Abstract][Full Text] [Related]
30. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
[TBL] [Abstract][Full Text] [Related]
31. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease.
Head MW; Northcott V; Rennison K; Ritchie D; McCardle L; Bunn TJ; McLennan NF; Ironside JW; Tullo AB; Bonshek RE
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):342-6. PubMed ID: 12506094
[TBL] [Abstract][Full Text] [Related]
32. Classification of sporadic Creutzfeldt-Jakob disease revisited.
Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
[TBL] [Abstract][Full Text] [Related]
33. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
[TBL] [Abstract][Full Text] [Related]
34. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.
Polymenidou M; Stoeck K; Glatzel M; Vey M; Bellon A; Aguzzi A
Lancet Neurol; 2005 Dec; 4(12):805-14. PubMed ID: 16297838
[TBL] [Abstract][Full Text] [Related]
35. Creutzfeldt-Jakob disease (CJD) of a short duration with prion protein (PrP) plaques.
Liberski PP; Kwieciński H; Barcikowska M; Mirecka B; Kulczycki J; Kida E; Brown P; Gajdusek DC
Patol Pol; 1991; 42(4):115-8. PubMed ID: 1845486
[TBL] [Abstract][Full Text] [Related]
36. High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease.
Matsui Y; Satoh K; Miyazaki T; Shirabe S; Atarashi R; Mutsukura K; Satoh A; Kataoka Y; Nishida N
BMC Neurol; 2011 Oct; 11():120. PubMed ID: 21970675
[TBL] [Abstract][Full Text] [Related]
37. The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with beta-amyloid deposits in Alzheimer's disease.
Armstrong RA; Lantos PL; Cairns NJ
Neurosci Lett; 2001 Jan; 298(1):53-6. PubMed ID: 11154834
[TBL] [Abstract][Full Text] [Related]
38. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease.
Zanusso G; Monaco S; Pocchiari M; Caughey B
Nat Rev Neurol; 2016 Jun; 12(6):325-33. PubMed ID: 27174240
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P
Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases.
Völkel D; Zimmermann K; Zerr I; Bodemer M; Lindner T; Turecek PL; Poser S; Schwarz HP
Transfusion; 2001 Apr; 41(4):441-8. PubMed ID: 11316892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
